Diffuse hair loss: Its triggers and management

Cleveland Clinic Journal of Medicine

Volumn 76, Issue 6, 2009, Pages 361-367

  Harrison, Shannon ^a   Bergfeld, Wilma ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ALOPECIA; ALOPECIA AREATA; CHEMICALLY INDUCED DISORDER; DIET; DIFFERENTIAL DIAGNOSIS; FEMALE; GROWTH, DEVELOPMENT AND AGING; HAIR; HUMAN; MALE; MENTAL STRESS; PATHOLOGY; PATIENT EDUCATION; PHYSIOLOGICAL STRESS; PHYSIOLOGY; REVIEW;

ALOPECIA; ALOPECIA AREATA; DIAGNOSIS, DIFFERENTIAL; DIET; FEMALE; HAIR; HUMANS; MALE; PATIENT EDUCATION AS TOPIC; PHARMACEUTICAL PREPARATIONS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 67149128623     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.76a.08080     Document Type: Review

References (24)

1. Bergfeld WF, Mulinari-Brenner F. Shedding: how to manage a common cause of hair loss. Cleve Clin J Med 2001; 68: 256-261.
2. Headington JT. Telogen effluvium: new concepts and review. Arch Dermatol 1993; 129: 356-363.
3. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol 2002; 27: 389-395.
4. Kligman AM. Pathologic dynamics of human hair loss. I. Telogen effluvium. Arch Dermatol 1961; 83: 175-198.
5. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999; 341: 491-497.
6. Rook A, Dawber R. Chapter 1. The comparative physiology, embryology and physiology of human hair. In: Rook A, Dawber R, eds. Diseases of the Hair and Scalp. Oxford, UK: Blackwell Science Publications; 1982:1-17.
7. Bergfeld WF. Chapter 9. Telogen effluvium. In: McMichael J, Hordin MK, eds. Hair and Scalp Diseases: Medical, Surgical, and Cosmetic Treatments. London, UK: Informa Health Care; 2008:119-136.
8. Sinclair RD, Dawber RP. Androgenetic alopecia in men and women. Clin Dermatol 2001; 19: 167-178.
9. Sperling LC. Hair and systemic disease. Dermatol Clin 2001; 19: 711-726.
10. Tosti A, Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatol Clin 2007; 25: 223-231.
11. Rook A, Dawber R. Chapter 5. Diffuse alopecia: endocrine, metabolic and chemical influences on the follicular cycle. In: Rook A, Dawber R, eds. Diseases of the Hair and Scalp. Oxford, UK: Blackwell Science Publications; 1982: 115-145.
12. Goette DK, Odum RB. Alopecia in crash dieters. JAMA 1976; 235: 2622-2623.
13. Pillans PI, Woods DJ. Drug-induced alopecia. Int J Dermatol 1995; 34: 149-158.
14. Fiedler VC, Gray AC. Chapter 10. Diffuse alopecia: telogen hair loss. In: Olsen EA, ed. Disorders of Hair Growth: Diagnosis and Treatment. 2nd ed. New York, NY: McGraw-Hill Publishing; 2003: 303-320.
15. Apache PG. Eczematous dermatitis of the scalp. In: Zviak C, ed. The Science of Hair Care. New York, NY: Marcel Dekker, 1986: 513-521.
16. Whiting DA. Chronic telogen effluvium. Dermatol Clin 1996; 14: 723-731.
17. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 1996; 35: 899-906.
18. Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 2005; 52: 301-311.
19. Sinclair R, Grossman KL, Kvedar JC. Chapter 9: Anagen hair loss. In: Olsen EA, ed. Disorders of Hair Growth: Diagnosis and Treatment. 2nd ed. New York, NY: McGraw-Hill Publishing; 2003: 275-302.
20. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000; 42: 549-566.
21. Shapiro J. Clinical practice. Hair loss in women. N Engl J Med 2007; 357: 1620-1630.
22. Piérard GE, Piérard-Franchimont C, Marks R, Elsner P; EEMCO group (European Expert Group on Efficacy Measurement of Cosmetics and other Topical Products). EEMCO guidance for the assessment of hair shedding and alopecia. Skin Pharmacol Physiol 2004; 17: 98-110.
23. Sellheyer K, Bergfeld WF. Histopathologic evaluation of alopecias. Am J Dermatopathol 2006; 28: 236-259.
24. Burke BM, Cunliffe WJ. Oral spironolactone therapy for female patients with acne, hirsutism, and androgenetic alopecia. Br J Dermatol 1985; 112: 124-125.